BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17674361)

  • 1. Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution.
    Nagayama K; Kohno T; Sato M; Arai Y; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2007 Nov; 46(11):1000-10. PubMed ID: 17674361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
    Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
    Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
    Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.
    Yamakawa K; Takahashi T; Horio Y; Murata Y; Takahashi E; Hibi K; Yokoyama S; Ueda R; Takahashi T; Nakamura Y
    Oncogene; 1993 Feb; 8(2):327-30. PubMed ID: 8381220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.
    Kohno T; Otsuka A; Girard L; Sato M; Iwakawa R; Ogiwara H; Sanchez-Cespedes M; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2010 Apr; 49(4):342-52. PubMed ID: 20073072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer.
    Yamada H; Yanagisawa K; Tokumaru S; Taguchi A; Nimura Y; Osada H; Nagino M; Takahashi T
    Genes Chromosomes Cancer; 2008 Sep; 47(9):810-8. PubMed ID: 18523997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma.
    Kohno T; Kawanishi M; Matsuda S; Ichikawa H; Takada M; Ohki M; Yamamoto T; Yokota J
    Genes Chromosomes Cancer; 1998 Mar; 21(3):236-43. PubMed ID: 9523199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.
    Angeloni D; ter Elst A; Wei MH; van der Veen AY; Braga EA; Klimov EA; Timmer T; Korobeinikova L; Lerman MI; Buys CH
    Genes Chromosomes Cancer; 2006 Jul; 45(7):676-91. PubMed ID: 16607615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
    Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
    Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
    Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
    Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
    Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
    Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
    Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
    Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
    Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
    Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
    Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.